ABBOTT LABORATORIES

Member Only Articles

AI Health Factor Performance Trends

Latest Insights

24 January, 2025
Abbott Laboratories Earns Buy Rating as Strong Growth Prospects and Outperforming Shares Shine in Medical Sector Analysis
Read More >>
23 January, 2025
Abbott Laboratories Earns Buy Rating as Strong Growth Prospects and Outperforming Shares Shine in Medical Sector Analysis
Abbott Laboratories continues to strengthen its footprint in the medical sector, boasting a favorable Zacks Rank of #2 (Buy) as of January 2025. The company's estimated earnings growth rate stands at ...
Read More
22 January, 2025
Abbott Laboratories Achieves Strong Earnings Growth Projections Amid Competitive Medical Sector Challenges
Abbott Laboratories (ABT) continues to signal strong potential for investors as it holds a Zacks Rank of 2 (Buy) with an anticipated earnings growth rate of 10% for 2025. This estimated growth reflect...
Read More
21 January, 2025
Abbott Laboratories Positioned for Growth with 10% Earnings Increase Projected for 2025
Abbott Laboratories (ABT) is currently positioned as a strong investment opportunity with a Zacks Rank of 2, indicating a "Buy" rating. The company is expected to achieve an estimated earnings growth ...
Read More
20 January, 2025
Abbott Laboratories Positioned for Growth with 10% Earnings Increase Expected for 2025 Amidst Competitive Market
Abbott Laboratories (ABT) is demonstrating promising growth potential as we enter 2025, supported by a solid estimated earnings growth rate of 10%. The company currently holds a Zacks Rank of 2 (Buy),...
Read More

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.